Last reviewed · How we verify

NCT03401424

Comparison of Two Kinds of Biliary Intestinal Reconstruction in Cholangiectasia

Status unknown NA Last updated 17 January 2018
What this trial tests

NA trial testing improved Warren-type style in Postcholecystectomy Syndrome in 120 participants. Status unknown.

Timeline
1 June 2017
Primary endpoint
1 June 2019
1 June 2020

Quick facts

Lead sponsorSouthwest Hospital, China
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment120
Start date1 June 2017
Primary completion1 June 2019
Estimated completion1 June 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Southwest Hospital, China

Who can join

Adults 5 to 70, any sex, with Postcholecystectomy Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To observe and compare the short-term and long-term effects of different biliary and intestinal reconstruction methods for the treatment of congenital cystic dilatation of bile duct .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postcholecystectomy Syndrome

Currently open trials in the same condition.

Other Southwest Hospital, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03401424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing